Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...
THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...
News Medical on MSN3h
Weekly diabetes injection could replace daily shots for lipodystrophy patientsRutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.
Zacks.com on MSN7h
Brian's Big Idea: Healthcare StocksOne of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines, ...
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
AMA President Dr Danielle McMullen provides an update on the past week at Federal AMA. What a whirlwind week it's been!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback